Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03056599
Title Precise Local Injection of Anti-cancer Drugs Using Presage's CIVO™ Device in Soft Tissue Sarcoma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Presage Biosciences
Indications

sarcoma

Therapies

Pembrolizumab

Avelumab

Interferon gamma

Olaratumab

Trabectedin

Nivolumab

Gemcitabine

Interferon alpha-2b

Doxorubicin

Atezolizumab

Eribulin

Ipilimumab

Durvalumab

Aldesleukin

Bortezomib

Docetaxel

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.